Hypoxia-induced mitochondrial silencing as a proposed third axis of apoptosis control in solid tumors: a dual hypothesis linking initiation–promotion transition to hypoxic niche maintenance

• Mitochondrial silencing is defined as preserved structure with reduced apoptotic execution capacity • Hypoxia-induced mitochondrial silencing may permit survival in initiation–promotion. • Pathological angiogenesis may stabilize hypoxic niches that maintain silencing. • Silent mitochondria are proposed as a third apoptosis axis beyond pro/anti signaling. Cancer initiation and progression have traditionally been interpreted primarily through the accumulation of genetic mutations and the dysregulation of intracellular signaling pathways. At the same time, increasing evidence indicates that the tumor microenvironment—particularly hypoxia and pathological angiogenesis—plays a critical role in tumor cell survival, clonal selection, and therapeutic resistance. However, how genetic alterations and hypoxia-driven metabolic adaptation are functionally integrated during stepwise tumor progression remains incompletely understood. In this manuscript, we propose a dual hypothesis framework in which hypoxia-induced mitochondrial silencing and hypoxic niches maintained by pathological angiogenesis cooperatively shape cancer progression in hypoxia-prone solid tumors. Mitochondrial silencing is defined here as a functional mitochondrial state in which oxidative metabolism is suppressed and the executional capacity of mitochondria-dependent apoptosis is attenuated, despite the structural persistence of mitochondria. We further propose that this state functions as a third regulatory layer of apoptosis control, distinct from classical pro- and anti-apoptotic signaling pathways. As a second component of the hypothesis, we suggest that structurally and functionally abnormal tumor neovasculature generates spatially heterogeneous microenvironments characterized by limited red blood cell–mediated oxygen delivery but relatively preserved diffusion of glucose. Such hypoxic, glucose-accessible niches are predicted to preferentially select for and maintain cell populations adapted to mitochondrial silencing and glycolysis-dominant metabolism, thereby supporting clonal persistence, heterogeneity, and progression. Although this work does not present experimental data, it provides a testable conceptual framework that repositions mitochondrial functional state as a central integrator of genetic alterations and microenvironmental constraints, and offers new perspectives on apoptosis resistance and metabolic adaptation in hypoxic solid tumors.